Vulvovaginal candidiasis: Risk factors and clinical and mycological characteristics;Les candidoses vulvovaginales : facteurs de risque et particularités cliniques et mycologiques

Journal de Mycologie Medicale

Volumn 20, Issue 1, 2010, Pages 36-41

  Anane, S ^a   Kaouech, E ^a   Zouari, B ^b   Belhadj, S ^a   Kallel, K ^a   Chaker, E ^a  

^a LA RABTA HOSPITAL   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Diagnosis; Risk factors; Tunisia; Vulvovaginal candidiasis

Indexed keywords

ABORTION; ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DYSPAREUNIA; FEMALE; FUNGAL EXAMINATION; FUNGUS ISOLATION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PARITY; PERSONAL HYGIENE; PREGNANCY; RECURRENT DISEASE; REPRODUCTIVE HEALTH; RISK FACTOR; TUNISIA; VAGINA CANDIDIASIS; VAGINA DISCHARGE; VULVA PRURITUS;

CANDIDA ALBICANS;

EID: 77549088356     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mycmed.2010.01.001     Document Type: Article

References (27)

1. Bauters T.G.M., Dhont M.A., Temmerman M.I.L., and Nelis H.J. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am. J. Obstet. Gynecol. 187 (2002) 569-574
2. Bohannon N.J.V. Treatment of vulvovaginal candidiasis in patients with diabetes. Diabetes Care 21 (1998) 451-456
3. Bouguerra R., Essaïs O., Sebaï N., Ben Salem L., Amari H., Kammoun M.R., et al. Prévalence et aspects cliniques des mycoses superficielles. Med. Mal. Inf. 34 (2004) 201-205
4. Chassot F., Negri M.F.N., Svidzinski A.E., Donatti L., Peralta R.M., Svidzinski T.I.E., et al. Can intrauterine contraceptive devices be a Candida albicans reservoir?. Contraception 77 (2008) 355-359
5. De leon E.M., Jacober S.J., Sobel J.D., and Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect. Dis. 2 (2002) 1-6
6. Demirezen S., Dirlik O.O., and Beksac M.S. The association of Candida infection with intrauterine contraceptive device. Cent. Eur. J. Public Health 13 (2005) 32-34
7. Fox H. Genital candidosis in general practice. J. R. Coll. Gen. Pract. 34 (1984) 449-450
8. Foxman B. The epidemiology of vulvovaginal candidiasis: risk factors. Am. J. Public Health 80 (1990) 329-331
9. Glover D.D., and Larsen B. Relationship of fungal vaginitis therapy to prior antibiotic exposure. Infect. Dis. Obstet. Gynecol. 11 (2003) 157-160
10. Grigoriou O., Baka S., Makrakis E., Hassiakos D., Kapparos G., and Kouskouni E. Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors. Eur. J. Obstet. Gynecol. Reprod. Biol. 126 (2006) 121-125
11. Hodoglugil N.N.S., Aslan D., and Bertan M. Intrauterine device use and some issues related to sexually transmitted disease screening and occurrence. Contraception 61 (2000) 359-364
12. N. Jindal, P. Gill, A. Aggarwal. An epidemiological study of vulvovaginal candidiasis in women of childbearing age. www.ijmm.org. 25 (2007) 175-6.
13. Karaer A., Boylu M., and Avsar A.F. Vaginitis in Turkish women: symptoms, epidemiologic-microbiologic association. Eur. J. Obstet. Gynecol. Reprod. Biol. 121 (2005) 211-215
14. Linhares L.M., Witkin S.S., Miranda S.D., Fonseca A.M., Pinotti J.A., and Ledger W.J. Differenciation between women with vulvovaginal symptoms who are positive or negative for Candida species by culture. Infect. Dis. Obstet. Gynecol. 9 (2001) 221-225
15. Malazy O.T., Shariat M., Heshmat R., Majlesi F., Alimohammadian M., Tabari N.K., et al. Vulvovaginal candidiasis and its related factors in diabetic women. Taiwan J. Obstet. Gynecol. 46 (2007) 399-404
16. Moreira D., and Paula C.R. Vulvovaginal candidiasis. Int. J. Gynecol. Obstet. 92 (2006) 266-267
17. Nyirjesy P., and Sobel J.D. Vulvovaginal candidiasis. Obstet. Gynecol. Clin. N. Am. 30 (2003) 671-684
18. Parveen N., Munir A.A., Din I., and Majeed R. Frequency of vaginal candidiasis in pregnant women attending routine antenatal clinical. J. Coll. Physicians Surg. Pak. 18 (2008) 154-157
19. Richter S.S., Galask R.P., Messer S.A., Hollis R.J., Diekema D.J., and Pfaller M.A. Antifungal susceptibilities of Candida Species causing vulvovaginitis and epidemiology of recurrent cases. J. Clin. Microbiol. 43 (2005) 2155-2162
20. Ringdahl E.N. Treatment of recurrent vulvovaginal candidiasis. Am. Fam. Physician 61 (2000) 3306-3312
21. Rowe B.R., Logan M.N., Farrell I., and Barnett A.H. Is candidiasis the true cause of vulvovaginal irritation in women with diabetes mellitus?. J. Clin. Pathol. 43 (1990) 644-645
22. Rylander E., Berglund A.L., Krassny C., and Petrini B. Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. Sex. Transm. Inf. 80 (2004) 54-57
23. Senterre J.M., Carpentier M., and Foidart J.M. Prévalence des différentes espèces de Candida au niveau vaginal dans la région Liégeoise. Rev. Med. Liege 60 (2005) 882-884
24. Spinillo A., Cappuzzo E., Acciano S., De Santolo A., and Zara F. Effect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis. Am. J. Obstet. Gynecol. 180 (1999) 14-17
25. Sobel J.D. Vulvovaginal candidosis. Lancet 369 (2007) 1961-1971
26. Sobel J.D., Faro S., Force R.W., Foxman B., Ledger W.J., Nyirjesy P.R., et al. Vulvovaginal candidiasis: Epidemiologic, diagnostic and therapeutic considerations. Am. J. Obstet. Gynecol. 178 (1998) 203-211
27. Spinillo A., Capuzzo E., Egbe T.O., Baltaro F., Nicola S., and Piazzi G. Torulopsis glabrata vaginitis. Obstet. Gynecol. 85 (1995) 993-998